BillionToOne BLLN 深 沪
等待开盘 09-18 09:30:00 美东时间
110.67
+7.060
+6.81%
华盛通- 最 高111.00
- 今 开105.36
- 成交量 54.73万股
- 最 低 104.485
- 昨 收 103.61
- 总市值 52.22亿
- 52周最高 150.44
- 市盈率 静 1737.36
- 换手率 1.16%
- 52周最低 61.96
- 委 比 -36.05%
- 总股本 4718.70万
- 历史最高 150.44
- 量 比 1.17
- 振 幅 6.29%
- 历史最低 61.96
- 每 手 1
- 风险率 17.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 最高735美元！戴尔科技绩后获11家大行上调目标价；MongoDB绩后分歧大，9家上调；4家下调；派拓网络、GitLab、美敦力获多家大行上调目标价
今日重点评级关注：Tigress Financial：维持Liftoff Mobile"买入"评级，目标价从39美元升至41美元；奥本海默：维持SpaceX"跑赢大市"评级，目标价从250美元升至280美元
09-03 13:50
Canaccord Genuity Initiates Coverage On BillionToOne with Buy Rating, Announces Price Target of $120
Canaccord Genuity analyst Kyle Mikson initiates coverage on BillionToOne (NASDAQ:BLLN) with a Buy rating and announces Price Target of $120.
09-02 23:42
BillionToOne Publishes NIPT Study Titled A Prospective, Multi-Site Study Of Performance Of Cell-Free DNA Testing For Recessive Conditions In A Large, General-Risk Pregnancy Population
BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced publication of A Prospective, Multi-Site Study of Performance of Cell-Free DNA Testing for Recessive Conditions in a Lar...
08-19 00:16
BillionToOne, Inc. Class A Signals Robust Growth
BillionToOne, Inc. Class A (($BLLN)) has held its Q2 earnings call. Read on for...
08-12 08:24
美股周涨跌榜 | 心血管药企Braveheart Bio上市首周大升66.7%；多只绩优股飙升！IOVA周升逾55.8%，Atlassian周升逾47%
心血管药企Braveheart Bio上市首周大升66.7%；多只绩优股飙升！IOVA周升逾55.8%，季报营收创新高；Atlassian周升逾47%，第四财季营收同比增长27.6%>>
08-08 09:48
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
BillionToOne sinks as outlook unchanged despite surging revenue
Following more than a twofold rise over the past four months, BillionToOne (BLLN) shares plunged more than 39% on Thursday after the molecular diagnostics firm, with its Q2 2026 results, reiterated it...
08-07 02:23
BTIG Maintains Buy on BillionToOne, Lowers Price Target to $130
BTIG analyst Mark Massaro maintains BillionToOne (NASDAQ:BLLN) with a Buy and lowers the price target from $142 to $130.
08-06 17:51
美股夜盘 | SiTime Corporation暴升32.41%，SoundHound AI暴升23.17%
SiTime Corporation暴升32.41%；SoundHound AI暴升23.17%；Caris Life Sciences劲升12.22%
08-06 15:01
BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move
BillionToOne, Inc. (NASDAQ:BLLN) shares fell 28.12% in Wednesday’s after-hours session after the company reported its second-quarter financial results. The stock closed Wednesday’s regular session up 5.43% at $149.97 before falling 28.12% to $107.80 in after-hours trading. BillionToOne is a molecula...
08-06 14:01
